Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors GERMANTOWN, Md., July 18, 2019 /PRNewswire/ — Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous [….]